The role of ion channelopathies in sudden cardiac death: implications for clinical practice

Claire A Martin1, Christopher L-H Huang, Gareth D K Matthews

  • 1Physiological Laboratory, University of Cambridge, Downing Site, Cambridge CB2 3EG, UK. clairemartin@gmail.com

Annals of Medicine
|May 9, 2013
PubMed

Insights

Sudden cardiac death (SCD) can occur in hearts without structural abnormalities due to ion channel dysfunction. Understanding these genetic and molecular mechanisms is crucial for developing new diagnostic and therapeutic strategies.

Area of Science:

  • Cardiology
  • Molecular Medicine
  • Genetics

Background:

  • Sudden cardiac death (SCD) is a significant cause of mortality, with a subset of cases linked to ion channel dysfunction in structurally normal hearts.
  • Electrophysiological disturbances, including altered action potential conduction and calcium homeostasis, can trigger life-threatening ventricular tachyarrhythmias.
  • Patients may experience symptoms like syncope or palpitations, necessitating early diagnosis and intervention.

Purpose of the Study:

  • To review recent advancements in the pathophysiological understanding of SCD.
  • To bridge the gap between molecular mechanisms and clinical practice in managing SCD.
  • To highlight the implications of genetic discoveries for diagnosis and therapy.

Main Methods:

  • Review of current literature on ion channel-mediated SCD.
  • Analysis of pathophysiological mechanisms underlying arrhythmias.
  • Discussion of emerging diagnostic and therapeutic approaches.

Main Results:

  • Ion channel alterations can lead to arrhythmogenic consequences even in structurally normal hearts.
  • Genetic testing is becoming increasingly vital for diagnosing inherited cardiac conditions.
  • Novel pharmacological and gene-specific therapies are under development.

Conclusions:

  • A deeper understanding of molecular pathways is essential for improving SCD risk stratification and management.
  • Integrated approaches combining genetic insights with clinical practice are key to advancing patient care.
  • Future directions include personalized gene-specific therapies for inherited arrhythmic syndromes.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...